Slide 1Pandemic influenza A (2009) Clinical Controversies in Clinical Care: What worked and what did not David SC Hui MBBS, MD(UNSW), FRACP, FRCP, FCCP, FHKCP, FHKAM Professor,…

Slide 1Brentuximab Vedotin. How and When Should it be Used in B and T cell Lymphomas Ranjana Advani MD Professor of Medicine Saul Rosenberg Professor of Lymphoma Stanford…

Page 1 Lymphomes Page 2 Y a t il une place pour l allogreffe ? Page 3 Mini allo: retrospective EBMT Robinson SP et al Blood 2002;100: 4310 188 pts. Age médian: 40. Auto…

1.Advances in the treatment of T cell lymphomas Yok-Lam Kwong Department of Medicine Queen Mary Hospital 2. Mature T and NK cell malignancies T-cell prolymphocytic leukaemia…

1. Fungal infections in hematology patients: advances in prophylaxis and treatment Vincent CC Cheng MBBS (HK), MD (HK), PDipID (HK), MCRP (UK), FRCPath (UK), FHKCPath, FHKAM…

1 HCT Nonbranded Speaker Training Sample Show Deck Functional Test Only Hotel TBA Dallas, Texas February 1, 2013 2 Access to Health Care Is Defined as Receiving Timely Cost-Effective…

Slide 1 Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies Xiao-Jun Huang M.D. Ph.D. Peking University Institute of Hematology, Peking…

Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies Xiao-Jun Huang M.D. Ph.D. Peking University Institute of Hematology, Peking University…

Steven M. Horwitz M.D. Associate Attending Memorial Sloan-Kettering Cancer Center Associate Professor Weill Cornell Medical College 3 questions How do we best deploy novel…

Timing of Transplant for Multiple Myeloma Robert Z. Orlowski, Ph.D., M.D. Director, Myeloma Section Professor, Departments of Lymphoma/Myeloma & Experimental Therapeutics…